alliance management

 Lyell Immunopharma a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors announced that Matthew Lang, J.D. has joined the executive management team as Chief Business…
Read More...

Mr. Moss to also Serve as Corporate Secretary and Chief Compliance Officer Evommune, Inc., a clinical stage, biotechnology company dedicated to the development of transformative medicines for inflammatory diseases,announced the appointment…
Read More...